Multi-task deep learning model for predicting EGFR mutation status in NSCLC.

Authors

Qilong Song, Xiaohu Li, Biao Song, Wei Ye, Tingting Zhang, Xiankuo Hu, Chi Cao, Ao Li, Xuhong Min, Yongqiang Yu

Published in

NPJ digital medicine. Jul 20, 2026. Epub Jul 20, 2026.

Abstract

Multi-task DL for predicting EGFR mutation status Epidermal growth factor receptor (EGFR) mutation status is a critical biomarker in the management of non-small cell lung cancer (NSCLC), playing an essential role in selecting patients for EGFR-targeted treatment. With advancements in deep learning (DL), there is a growing interest in developing non-invasive methods for predicting EGFR mutation status. In this study, we present a multi-task deep learning (MTDL) model that utilizes CT images to predict EGFR mutation status (ChiCTR2400083082 in the WHO International Clinical Trials Registry). Our MTDL model achieved promising performance in accurately predicting EGFR mutation status. Additionally, the MTDL score was significantly associated with survival in patients receiving EGFR-targeted treatment, as well as relevant gene expression patterns and tumor microenvironment. These findings suggest that our method has the potential to serve as an accurate and non-invasive biomarker for predicting EGFR mutation status, thereby facilitating personalized treatment decisions for NSCLC patients.

PMID:
42477500
Bibliographic data and abstract were imported from PubMed on 21 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.